Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge

作者：Lindsey Robert Baden, Hana M. El Sahly, Brandon J. Essink, Dean A. Follmann, Kathleen Maletic Neuzil, Allison August, Heather Clouting, Gabrielle Fortier, Weiping Deng, Shu Han, Xiaoping Zhao, Brett A. Leav, Carla A. Talarico, Bethany Girard, Yamuna Devi Paila, Joanne E. Tomassini, Florian P. Schödel, Rolando Pajón, Honghong Zhou, Rituparna Das, Jacqueline M. Miller · 发表于：New England Journal of Medicine · 年份：2021 · DOI：10.1056/nejmc2115597 · 被引用次数：63 · 研究领域：SARS-CoV-2 and COVID-19 Research、Viral Infections and Immunology Research、Virus-based gene therapy research

mRNA-1273 Vaccine Efficacy against the Delta Variant Participants who had received placebo in a previous phase of this trial were offered the mRNA-1273 vaccine in the open-label phase. The incidenc...